Physician profile
Glenn S Fuoco
NPI 1912989625
$375.75
in general payments reported to CMS, 2019-2025
12 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $34.13 · 2021: $15.95 · 2022: $23.07 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $171.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $88.29 | 2025 | Wavewriter Alpha Prime 16, Intracept |
| Horizon Therapeutics Plc | $44.80 | 2019-2021 | |
| Pacira Therapeutics, INC. | $42.94 | 2019 | |
| Abbott Laboratories | $38.57 | 2025 | Proclaim, Eterna |
| Bioventus LLC | $34.47 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Acumed LLC | $23.07 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $21.64 | 2025 | |
| Arbor Pharmaceuticals, INC. | $18.06 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $17.33 | 2019 | |
| Electronic Waveform Lab, INC. | $17.13 | 2019 | |
| Kaleo, INC. | $16.07 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Fuoco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.